Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOBRAMYCIN vs TOLVAPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOBRAMYCIN vs TOLVAPTAN: Safety Overview

Metric TOBRAMYCIN TOLVAPTAN
Total FAERS Reports 11,597 9,014
Deaths Reported 1,306 1,709
Death Rate 11.3% 19.0%
Hospitalizations 5,106 2,467
Average Patient Age 38.0 yrs 56.2 yrs
% Female Patients 54.0% 52.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 23, 2018
Manufacturer Lifestar Pharma LLC Otsuka America Pharmaceutical, Inc.
Route RESPIRATORY (INHALATION) ORAL
Marketing Status Discontinued Prescription